Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
Holders of 5% or more of CARM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Carisma Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Carisma Therapeutics Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Carisma Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 20254:30 PM ET | HealthCap VII, L.P.and 1 other | 13D/A | 0.00%0 shares | −4.80 ppfrom 4.80%Below 5% | Sep 2, 2025 | SEC |
| Aug 29, 20255:55 PM ET | HealthCap VII, L.P.and 1 other | 13D/A | 4.80%2.01M shares | −1.70 ppfrom 6.50%Below 5% | Aug 27, 2025 | SEC |
| Aug 21, 20255:57 PM ET | HealthCap VII, L.P.and 1 other | 13D/A | 6.50%2.72M shares | – | Aug 19, 2025 | SEC |
| Apr 25, 20254:15 PM ET | AbbVie Biotechnology Ltd | 13G/A | 4.40%1.86M shares | –Below 5% | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Carisma Therapeutics Inc. shares.
No Form 144 notices for Carisma Therapeutics Inc. are on file.